Covivio (ENXTPA:COV) Faces A Pullback, Is It Cheap At Current Levels?

Covivio (ENXTPA:COV) has drawn investor attention after recent price moves, with the share price near €48.08 and performance over the past month and past 3 months showing clear declines.

Short-term momentum for Covivio looks weak, with the 1-month share price return down 6.46% and the year-to-date share price return down 14.07%, even though the 3-year total shareholder return is up 37.56%. This hints at fading near-term enthusiasm despite a stronger long-run history.

Scan beyond Covivio's recent pullback and compare it with a curated 177 high quality undervalued stocks that share solid fundamentals and may be offering mispriced entry points right now.

Covivio still has a sizeable €5.3b footprint and a 3 year total return that is firmly positive, yet the share price has pulled back hard. Is that business strength already reflected in the price or not?

Most Popular Narrative: 23% Undervalued

The most followed valuation view on Covivio pegs fair value at €62.21, comfortably above the recent €48.08 close. This frames the pullback as a potential discount rather than a permanent reset in expectations.

The asset swap with AccorInvest to merge hotel operations is expected to yield significant long-term benefits, including higher EBITDA yield from CapEx investments, enhancing future earnings potential.

The company is leveraging its investments in Southern Europe's hotel market, an area poised for growth, to increase revenue streams through high-yield, mixed fixed and variable lease agreements, further contributing to earnings enhancement.

See why 7 investors see Covivio as 23% undervalued.

The fair value estimate in this narrative leans on an 8.75% discount rate and a central case that points to steady profit margins near 61.9%, even as revenue is modeled to drift lower over time. At €62.21 per share, that framework implies Covivio trades at a clear markdown to what those assumptions suggest, while still acknowledging the drag from forecast revenue declines and a relatively modest 5.9% future return on equity.

Put differently, analysts behind this storyline accept that Covivio may face shrinking top line and lower quality earnings due to one off items. Yet they still see the current €5.3b market value as leaving room above today’s quote if those hotel and office portfolios perform roughly in line with their work. That combination of a discounted price, solid historical 3 year total return of 37.56%, and a narrative that builds in both execution risk and sector pressure underpins the 23% undervalued label rather than a stretch case.

Result: Fair Value of €62.21 (UNDERVALUED)

Still, the Covivio story can be knocked off course if German office values weaken further, or if more variable hotel leases make future cash flows less predictable.

Find out about the key risks to this Covivio narrative.

Next Steps

Mixed signals or a clear opening, either way Covivio deserves a closer look if you want your opinion to be grounded in the actual numbers and narrative. To weigh both sides of the story before it moves again, start with the 5 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Covivio?

If Covivio has sharpened your focus on value and risk, do not stop here. Use the Simply Wall Street Screener to quickly surface fresh, data backed ideas.

• Spot potential mispriced winners by scanning a 177 high quality undervalued stocks that combine solid fundamentals with market scepticism.
• Prioritise resilience and sleep easier at night by filtering for a 104 resilient stocks with low risk scores tailored to sturdier balance sheets and steadier returns.
• Get early to potential breakouts by hunting through a 618 high quality undiscovered gems before wider attention drives heavier interest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com